Deepali Balasubramani
@DeepaliBalasub1
Followers
100
Following
887
Media
0
Statuses
42
Ph.D. Student Biomedical Engineering @GeorgiaTech @EmoryUniversity @SinghLabGT; NIH T32 Immunoengineering Fellow
Atlanta, Georgia
Joined March 2020
RT @LLSusa: Some diffuse large B-cell lymphoma (DLBCL) patients—specifically African American patients and those with Epstein-Barr virus (E….
0
4
0
RT @Dr_ASingh: Pleased to share our new work @ScienceAdvances, led by @chengzhulab, revealing how forces regulate B cell & T cell synapse i….
0
4
0
RT @Dr_ASingh: For the 1st time, we can recreate & sustain “complex human immunological processes” in a synthetic gel; gamechanger for unde….
0
17
0
RT @Dr_ASingh: 🎉Huge congrats to my PhD student, Deepali Balasubramani (@DeepaliBalasub1), on receiving a prestigious NIH T32 ImmunoEnginee….
0
1
0
RT @ibbgatech: This morning, our immunoengineering group had a Immunoengineering Trainee Seminar, with presentations from two Ph.D. student….
0
1
0
RT @Dr_ASingh: Congrats to my @MEGeorgiaTech PhD student Zhe @MonicaZhong5 on receiving a '24 GT NEXT Award for engineering the human immun….
0
6
0
RT @Dr_ASingh: Exciting times! Highly motivated trainees are pushing new research boundaries in lab! @NSF GRFP @LucySBritto & @NIBIBgov Imm….
0
3
0
RT @ibbgatech: Spotlight on one of IBB's centers: the NIH has renewed its first T32 Research Program in ImmunoEngineering to help train the….
0
3
0
RT @nytimes: Bou Samnang, a Cambodian runner, had low blood pressure during the 5,000 meters at the Southeast Asian Games. She was last by….
0
473
0
RT @Dr_ASingh: Solid organ or hematopoietic stem cell transplant patients are at high risk for developing post-transplant lymphoproliferati….
0
6
0
I had a fantastic time at the Health Disparities in Hematologic Malignancies conference in NYC, attending talks and networking with leading experts in various aspects of this field from genomics, disease modeling , local/international outreach, and social determinants of health!.
The mentees, mentors, peers & collaborators!Excited to join my two talented PhD students, @LucySBritto & @DeepaliBalasub1, & internal medicine intern Dr. Michelle Lee, for being able to participate in Health Disparities conference, learn, & present work! Gr8 time in #Manhattan!
0
0
6
RT @Dr_ASingh: Excited to be back in NYC! Great start of “Health Disparities in Hematologic Malignancies: From Genes to Outreach” meeting w….
0
3
0
RT @CoulterBME: Making history! @CoulterBME ranks #⃣1⃣ in nation among graduate biomedical engineering programs in the nation! First time e….
0
23
0
RT @Dr_ASingh: It’s #glycotime when @CarolynBertozzi tweets about your research!! Thank you!! @shivemshah @SinghLabGT @mattdelisa Ty Moelle….
0
4
0
Looking forward to attending the Health Disparities in Hematologic Malignancies' conference this May in NYC!💃.
Invest early in them today, will set them up for career success tomorrow! Congrats 2 first year @SinghLabGT PhD students (@LucySBritto and @DeepaliBalasub1) on receiving travel awards to join cancer experts in NYC @ “Health Disparities in Hematologic Malignancies” conference!👏🏽
0
0
7
RT @gatechengineers: New treatments for a specific kind of lymphoma have shown promise, but 3 in 5 patients aren’t responding well in trial….
0
7
0
RT @Dr_ASingh: Thrilled to share our work in @NatureMaterials on profiling lymphoid tumor microenvironment & engineering Lymphoma organoids….
0
25
0
Groundbreaking bioengineered technologies developed by @SinghLabGT that model the lymphoid tumor microenvironment and enable further development of targeted cancer therapies👏.
Dr. Jean Koff, MD, Oncologist, on our .@NatureMaterials work: “From a clinician’s standpoint, this work is very exciting…it exemplifies how findings from large genomic datasets may be translated into development of therapeutic strategies in #lymphoma.” ➡️
0
0
4